简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-09-05 11:17 From AI-powered EHRs to Real-Time Data Sharing, InterSystems Asia Healthcare Summit 2025 Spotlights Indonesia as a Digital Health Beacon in Southeast Asia
2025-09-04 15:29 MRM Health Raises €55 Million Series B to Advance Best-in-Class Microbiome-Based Biotherapeutic Product Pipeline
2025-09-04 15:16 Biocytogen Enters into Agreement with Merck to Advance Antibody-Conjugated Lipid-Based Delivery Solutions
2025-09-04 10:26 Stallergenes Greer and Nuance Pharma Enter Exclusive Long-term Partnership for Actair® Sublingual Immunotherapy Tablet for the Treatment of House Dust Mite Allergy in China
2025-09-03 11:43 Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars
2025-09-03 10:46 Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcare Business Sector
2025-09-01 10:37 BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)
2025-08-29 11:15 Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
2025-08-27 18:58 EdgeConneX Establishes 350MW Data Center Platform in Japan's Powerhouse Region of Greater Osaka
2025-08-26 09:49 BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
2025-08-26 09:36 SBC Medical Appoints Dr. Ewen Chee as Lead Doctor for Asia Strategy to Accelerate Global Expansion
2025-08-22 10:29 European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications
2025-08-20 17:21 Cascale Annual Meeting to Challenge Consumer Goods Industry on Climate, Decent Work
2025-08-13 11:16 PL Developments Builds a Smarter, Healthier Supply Chain with Kinaxis
2025-08-08 14:37 BeOne Medicines Announces Second Quarter 2025 Financial Results and Business Updates
2025-08-06 09:43 Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016
2025-08-05 16:06 Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe
2025-08-05 10:36 Nucleus Network Acquires Hammersmith Medicines Research
2025-08-01 12:34 BeOne Medicines Receives PRIME Designation from the European Medicines Agency for BGB-16673 in Waldenstrom’s Macroglobulinemia
2025-07-30 15:18 Takeda Announces First-Quarter FY2025 Results With Significant Late-Stage Pipeline Progression

Business Wire Weibo

Press Releases

Latest Releases